Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

BIO Announces Additional Plenary Speakers for the 2012 World Congress to Address Advanced Biofuels, Renewable Chemicals and Creation of a Biobased Economy

Mar 8 2012
We are excited to offer this information-packed plenary program at the 2012 World Congress where speakers will highlight how industrial biotechnology leads to innovation and new jobs while helping to build a biobased economy.

2012 BIO International Convention Super Sessions Focus on Industry Outlook

Mar 7 2012
Global Event for biotechnology to be held June 18-21, 2012 in Boston, MA.

BIO Applauds House Committee Vote to Repeal IPAB

Mar 6 2012
BIO applauded the House Energy and Commerce Committee’s passage of the Medicare Decisions Accountability Act, H.R. 452, which would repeal the Independent Payment Advisory Board (IPAB) established in the health care reform law.

FAST Act Would Provide Patients with Accelerated Access to Innovative Therapies

Mar 6 2012
The FAST Act will modernize the Accelerated Approval pathway to expedite the development of modern, targeted, and personalized therapies for patients suffering from serious and life-threatening diseases, while preserving the Food and Drug Administration's (FDA) robust standards for safety and effectiveness. 

Biotech Leader Provides Testimony at Congressional Hearing on ‘Spurring Job Growth through Capital Formation While Protecting Investors’

Mar 6 2012
OncoMed Pharmaceuticals SVP/CFO provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs 

BIO Applauds Senator Stabenow’s Proposed Legislation Supporting Creation of a Biobased Economy

Mar 5 2012
New "Grow It Here, Make It Here" legislation introduced today by Sen. Debbie Stabenow (D-Mich.) would help bio-based manufacturers access vital capital, strengthen market opportunities for biobased products, and spur commercialization of agricultural and industrial biotech innovations.

BIO Announces Expansion of Alliance Development Activities

Mar 2 2012
The Biotechnology Industry Organization (BIO) announced today that it has integrated its alliance development activities into one department as a means of expanding engagement opportunities with external groups that share a commitment to unleashing biotechnology’s capability to benefit patients and consumers.

Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions

Feb 29 2012
Member companies of three leading advanced and cellulosic biofuel trade organizations sent a letter to House and Senate leaders asking for extension of the Cellulosic Biofuels Production Tax Credit, which expires December 31, 2012.

Commercialization of Advanced Biofuels to be Key Theme at BIO World Congress on Industrial Biotechnology and Bioprocessing

Feb 29 2012
Continued commercialization of the industrial biotechnology sector can drive the creation of a biobased economy, which can strengthen the nation’s economic security and enhance energy security. 

BIO Applauds Strengthening of the USDA BioPreferred Program

Feb 21 2012
BIO welcomes a White House memo to federal agencies that expands and strengthen the USDA BioPreferred program.